Gut bacteria in Parkinson's disease and related conditions
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how certain gut bacteria (methanogens) are involved in the progression of Parkinson's disease and related conditions. It aims to understand the connection between gut health and brain health, which may lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 years of age or older.
- You have Parkinson's disease, REM sleep behavior disorder, cognitive impairment (like dementia or mild cognitive impairment), or you are a healthy volunteer.
- You do not have other neurological, autoimmune, or metabolic diseases, active cancer, diabetes, or infections.
- You have not used immunosuppressive drugs in the last 12 months, steroids in the last 3 months, or regularly taken NSAIDs (like ibuprofen) or more than 75mg of aspirin.
- You have not participated in other interventional studies in the last 3 months.
- You are not currently a smoker.
- You can understand and speak English fluently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking probiotics can improve REM sleep behavior disorder (RBD) in people with Parkinson's disease. You will receive either a probiotic supplement or a placebo, and researchers will use brain scans to see how it affects your symptoms.
This study looks at how diet and the bacteria in your gut (microbiome) affect Parkinson's symptoms. You'll work with a coach and take cooking classes to see if changing what you eat can help you feel better.
This research examines how the gut and brain are connected in Parkinson's disease and aims to better understand the disease. You'd participate in visits and tests over three years, including some involving your digestive system.
This study looks at whether bacteria in the gut are different in people with early Parkinson's disease. It may help us understand the disease better and find new ways to treat it.
This Phase 2 study tests whether taking probiotics can improve depression and mood symptoms in people with Parkinson’s disease. It’s meant for those with mild to moderate depression and stable Parkinson’s and mood treatments.
This study looks at the gut bacteria and a chemical called tryptophan (found in some foods) in people with Parkinson's disease compared with healthy people. It may help explain how the gut relates to Parkinson's symptoms. Participants will be asked to provide a stool sample.
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.